quinta-feira, fevereiro 18, 2010

A farmácia do futuro (parte II)

Há anos que reflicto sobre a farmácia do futuro (por exemplo aqui:"Um caminho para a farmácia do futuro?" ) e não posso deixar de me sentir confortado com a confirmação em toda a linha das minhas visões para o negócio da farmácia do futuro que encontro neste artigo da revista strategy+business "The Pharmacy Solution".
.
Este tipo de futuro para a farmácia implica pensamento estratégico, implica escolhas, implica moldar o futuro.
.
"In the current environment, where easy access to cost-effective care is paramount, the pharmacy offers four significant advantages.
1. Trust. Patients already have more contact with pharmacists than other health-care providers and appear to greatly value their pharmacists’advice."
...
"2. Access. The pharmacist is highly accessible."
...
"3. Skills and services. Pharmacists are highly trained health professionals,knowledgeable about a range of medical conditions and
capable of delivering some advisory, diagnostic, and treatment services.
An increasing number of pharmacies also have a retail clinic on the premises, staffed by a nurse practitioner licensed to perform a range of primary care services and, in some cases, write prescriptions.
4. Cost. Retail pharmacies operate in a highly competitive business environment, and are already acting to keep the nation’s cost of prescription medications lower by promoting generics."
...
"Strategies for Pharmacies
As pharmacy companies plan for the future, they will need to first choose between two approaches for serving different patient segments consistently. The first is to build
retail health centers that focus on healthy and at-risk individuals and that deliver a range of health and wellness services, such as health risk assessments, counseling, smoking cessation programs, and ongoing tracking of risk factors.
...
The second approach is to concentrate on compliance and comprehensive disease management for the chronically ill. This population continues to grow, and more people are being forced to deal with multiple chronic conditions. Disease management (DM) companies are tackling the issue head on, but their efforts have not been fully satisfactory for the public or commercial payors"

1 comentário:

Peliteiro disse...

Excelente.
Copiei.
Abraço